Cargando…

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy

Detalles Bibliográficos
Autores principales: Hoch, Melanie, Hilfiker-Kleiner, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259998/
https://www.ncbi.nlm.nih.gov/pubmed/22084151
_version_ 1782221423729704960
author Hoch, Melanie
Hilfiker-Kleiner, Denise
author_facet Hoch, Melanie
Hilfiker-Kleiner, Denise
author_sort Hoch, Melanie
collection PubMed
description
format Online
Article
Text
id pubmed-3259998
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-32599982012-01-18 Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy Hoch, Melanie Hilfiker-Kleiner, Denise Oncotarget Editorial Comments Impact Journals LLC 2011-11-12 /pmc/articles/PMC3259998/ /pubmed/22084151 Text en Copyright: © 2011 Hoch and Hilfiker-Kleiner http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
spellingShingle Editorial Comments
Hoch, Melanie
Hilfiker-Kleiner, Denise
Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
title Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
title_full Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
title_fullStr Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
title_full_unstemmed Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
title_short Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
title_sort low-dose erythropoietin reduces risk of heart failure induced by anti-cancer therapy
topic Editorial Comments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259998/
https://www.ncbi.nlm.nih.gov/pubmed/22084151
work_keys_str_mv AT hochmelanie lowdoseerythropoietinreducesriskofheartfailureinducedbyanticancertherapy
AT hilfikerkleinerdenise lowdoseerythropoietinreducesriskofheartfailureinducedbyanticancertherapy